• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DuPont and Hohenstein to Launch New Testing Protocols for Body Armor Comfort and Mobility Assessment

    11/3/25 9:02:00 AM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email

    WILMINGTON, Del., Nov. 3, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of three innovative testing protocols that set a new benchmark for evaluating the comfort and mobility of soft ballistic body armor. Developed in collaboration with independent textile research and testing institute Hohenstein, the testing methods are designed to simulate real-world movements and situations to identify discomfort levels and mobility constraints faced by law enforcement and military personnel.

    DuPont and Hohenstein to Launch New Testing Protocols for Body Armor Comfort and Mobility Assessment

    Police officers often reference lack of comfort as a key reason for removing their body armor on duty. Additionally, restricted mobility leads to body fatigue, which weakens focus, slows reactions and increases the risk of injury.

    "Maximizing comfort and flexibility in soft ballistic solutions is essential to address the critical needs of law enforcement and military personnel," said Christophe Djololian, Global Market Development Leader at DuPont. "By taking into account body movement and specific end-use scenarios, we have developed solutions that more objectively evaluate discomfort and mobility constraints from the wearer's perspective."

    Three Comfort & Mobility Tests have been developed:

    • Lower Costal Bending (LCB) Test simulates upper body bending motions common in active duty, and measures energy loss due to armor stiffness, which can lead to accelerated fatigue in the field.
    • Double Curvature Compression (DCC) Test replicates a bent torso to assess how well ballistic materials conform to the body's complex curves. High conformability = enhanced freedom of movement.
    • Edge Pressure (EP) Test evaluates localized pressure points at the vest edges, such as the lower abdomen, neck and arms, which are often causes of discomfort.

    These test methods were developed in collaboration with Hohenstein, a German-based research institute with strong expertise in textile testing and ergonomics.

    "It is in the DNA of Hohenstein to get as close as possible to the user's reality," said Dr. Jan Beringer, Senior Scientific Expert at Hohenstein. "With dedicated wear trials, possible discomfort and movement restrictions were determined. Then, leveraging decades of expertise, tests and equipment were designed to simulate the wearer's experience in close collaboration between DuPont and Hohenstein."

    "It is our intent to drive the industry to more comfortable body armor to improve the performance and protection of military and law enforcement personnel. With these new comfort and mobility test protocols developed with Hohenstein, we can now quantify and standardize flexibility in body armor so protection and comfort go hand in hand. As we design new, more flexible materials such as Kevlar® EXO™ fabrics and structures, a wide range of highly optimized solutions for the greater benefit of end-users is now possible," said DuPont Global Segment Leader, Steven LaGanke.

    How to access the new testing protocols?

    The three test methods to characterize comfort & mobility constraints for soft ballistic applications are available on the Hohenstein website here.

    You can also learn more about the different testing methods here.

    About DuPont

    DuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets, including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

    About Hohenstein 

    Hohenstein is a family-owned company with more than 75 years of experience in testing, certification and research. Customers around the world benefit from a one-stop service: around 1,500 employees support businesses along the entire value chain, from testing and certification to marketing their products. Hohenstein's testing portfolio includes softlines – textile materials –, hardlines – consumer goods made from rigid materials –, as well as medical devices. As an accredited testing laboratory, Hohenstein Medical provides independent evidence of the effectiveness and safety of medical devices through biological, chemical and physical laboratory tests. The Hohenstein experts also support their customers with interdisciplinary knowledge for customised testing solutions beyond standard methods.

    www.hohenstein.com

    Media Contact:

    Olivia Stover

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-and-hohenstein-to-launch-new-testing-protocols-for-body-armor-comfort-and-mobility-assessment-302600514.html

    SOURCE DuPont Kevlar® EXO™

    Get the next $DD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DuPont Named Finalist in 2026 Edison Awards for FilmTec™ Fortilife™ XC160UHP Membrane for Wastewater Treatment and Reuse

    WILMINGTON, Del., Feb. 12, 2026 /PRNewswire/ -- DuPont (NYSE:DD) is proud to announce that its FilmTec™ Fortilife™ XC160UHP reverse osmosis elements for industrial wastewater treatment and reuse, has been honored as a finalist in the 2026 Edison Awards in the Water, Food and Agriculture category.  The FilmTec™ Fortilife™ XC160UHP element is a reverse osmosis element designed to concentrate wastewater streams, providing a more efficient and sustainable approach to water reuse and wastewater treatment. With the ability to operate under ultra-high-pressure conditions, FilmTec™ Fo

    2/12/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Reports Fourth Quarter and Full Year 2025 Results

    Exceeds Fourth Quarter and Full Year 2025 Guidance Initiates First Quarter and Full Year 2026 Guidance  Fourth Quarter 2025 Highlights Net Sales of $1.7 billion were flat; organic sales decreased 1% versus year-ago period including a $30 million, or 2%, headwind from the third quarter timing shiftGAAP Loss from continuing operations of $(108) million; operating EBITDA of $409 millionGAAP EPS from continuing operations of $(0.27); adjusted EPS of $0.46Cash provided by operating activities from continuing operations of $87 million, including $228 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $228 millionFull Year 2025 Highlights Net S

    2/10/26 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Expands Dairy Reverse Osmosis Portfolio with Mesh Wrapped FilmTec™ MXP RO-8038-FF Element

    New FilmTec™ MXP RO-8038-FF reverse osmosis element provides enhanced productivity and operational performance in a mesh wrapped configuration, enabling high-quality dairy products WILMINGTON, Del., Feb. 4, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the launch of the FilmTec™ MXP RO-8038-FF element—an advanced mesh wrapped reverse osmosis solution engineered for dairy processors who rely on mesh wrapped systems and now seek greater active area and higher productivity. As dairy producers seek to maximize throughput while maintaining trusted operational practices, Fil

    2/4/26 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Macpherson Donald G claimed no ownership of stock in the company (SEC Form 3)

    3 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/28/26 4:38:13 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Breen Edward D covered exercise/tax liability with 24,574 shares, decreasing direct ownership by 8% to 301,048 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/5/26 5:00:20 PM ET
    $DD
    Major Chemicals
    Industrials

    Senior Vice President & CHRO Raia Christopher covered exercise/tax liability with 2,793 shares, decreasing direct ownership by 3% to 80,255 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    1/5/26 4:59:10 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    SEC Filings

    View All

    DuPont de Nemours Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    2/10/26 6:06:47 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    1/20/26 5:00:08 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Other Events

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    12/4/25 4:42:35 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Reports Fourth Quarter and Full Year 2025 Results

    Exceeds Fourth Quarter and Full Year 2025 Guidance Initiates First Quarter and Full Year 2026 Guidance  Fourth Quarter 2025 Highlights Net Sales of $1.7 billion were flat; organic sales decreased 1% versus year-ago period including a $30 million, or 2%, headwind from the third quarter timing shiftGAAP Loss from continuing operations of $(108) million; operating EBITDA of $409 millionGAAP EPS from continuing operations of $(0.27); adjusted EPS of $0.46Cash provided by operating activities from continuing operations of $87 million, including $228 million of separation-related transaction cost and other payments; transaction-adjusted free cash flow of $228 millionFull Year 2025 Highlights Net S

    2/10/26 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Schedules Fourth Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., Jan. 21, 2026 /PRNewswire/ -- DuPont (NYSE:DD) will release its fourth quarter and full year 2025 financial results at 6:00 a.m. ET on Tuesday, February 10, 2026. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website. The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5

    1/21/26 8:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Reports Third Quarter 2025 Results; Announces Plans to Return Cash to Shareholders

    Exceeds 3Q 2025 Guidance for Total DuPont Raises FY 2025 Earnings Guidance for New DuPont Announces $2 Billion Share Repurchase Authorization, $500 Million Accelerated Share Repurchase and New DuPont Quarterly Dividend Third Quarter 2025 Highlights Net Sales of $3.1 billion increased 7%; organic sales increased 6% versus year-ago periodGAAP Income from continuing operations of $308 million; operating EBITDA of $840 millionGAAP EPS from continuing operations of $0.70; adjusted EPS of $1.09Cash provided by operating activities from continuing operations of $591 million; transaction-adjusted free cash flow of $576 millionRaises FY 2025 operating EBITDA guidance for new DuPont to $1.6 billionCap

    11/6/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    DuPont Announces Appointment of D.G. Macpherson to Board of Directors

    WILMINGTON, Del., Jan. 20, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of D.G. Macpherson to its Board of Directors, effective immediately. "We are very pleased to welcome D.G. to the DuPont board," said Lori Koch, DuPont Chief Executive Officer. "D.G. brings deep expertise in operational excellence, supply chain optimization, and business transformation, which will be invaluable as we execute our growth strategy and deliver long-term value to shareholders, customers, and employees. His passion for innovation and commitment to continuous improvement m

    1/20/26 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    Solstice Advance Materials and Qnity Electronics Set to Join S&P 500; Others to Join S&P SmallCap 600

    NEW YORK, Oct. 27, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P SmallCap 600: Solstice Advance Materials Inc. (NASD: SOLS) will replace CarMax Inc. (NYSE:KMX) in the S&P 500, and CarMax will replace USANA Health Sciences Inc. (NYSE:USNA) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 31. S&P 500 and 100 constituent Honeywell International Inc. (NASD: HON) is spinning off Solstice Advance Materials in a transaction expected to be completed on October 30. Post spin-off, Honeywell International will remain in the S&P 500 and 100. CarMax and USANA Health Sciences no longer represent the large cap and small c

    10/27/25 6:10:00 PM ET
    $CAL
    $DD
    $EMN
    Shoe Manufacturing
    Consumer Discretionary
    Major Chemicals
    Industrials

    DuPont Announces Appointment of Kurt McMaken to Board of Directors

    WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

    2/21/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials